Rising Number of Deaths Due to Rheumatic Heart Diseases to Accelerate Market Growth
As per the report published by the US National Health Statistics Report, GAS pharyngitis is one of the primary causes that has led to an increase in the number of patients being admitted to the emergency ward in the country. Moreover, group A beta-hemolytic streptococcus is one of the leading causes of streptococcal pharyngitis among adults and children. The diagnosis of strep throat is imperative and increasingly gaining momentum, owing to a surge in the number of deaths due to chronic rheumatic heart disease. GAS pharyngitis diagnostics has, thus, received a great amount of attention over the past few years and gained considerable traction across diagnostic laboratories, hospitals, and physician clinics worldwide.
Companies in the GAS pharyngitis diagnostics market are affected by a range of challenges. At present, one of the biggest challenges within the GAS pharyngitis diagnostics market is providing accurate, efficient, and accessible diagnostics. However, with significant groundwork, an influx of new training programs, growing support from government organizations, and promising outcome from R&D activities, GAS pharyngitis diagnostics is likely to gain significant momentum during the forecast period. Due to these factors, the global GAS pharyngitis diagnostics market is expected to attain a market value of ~ US $ 204 Mn by the end of 2027.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76521
Rapid Test Kits to Retain Popularity; Culture Tests Gain Ground
GAS pharyngitis diagnostics continues to remain a major challenge due to which, opting for the right treatment remains a constant roadblock. In the current scenario, antibiotics are primarily used to treat pharyngitis from bacterial infection. However, due to the significant rise in antimicrobial resistance, the adoption of antibiotics is declining-a factor that is expected to encourage research activities and finding an accurate diagnosis.
Culture tests are predominantly considered as the gold standard in the GAS pharyngitis diagnostics market. However, the downside of these culture-based tests includes the large time gap between sample collection and attaining results. Over the past decade, due to a significant amount of research and advancements in the medical field, an array of rapid tests have emerged within the GAS pharyngitis diagnostics market that is predominantly based on immunoassays and in recent times, on molecular assays. While immunoassays, including immunochromatographic assays, optical immunoassays, and enzyme immunoassays are deployed, molecular assays that are based on techniques such as polymerase chain reaction, DNA probes, and fluorescence in situ hybridization are also gaining considerable traction across the world.
Request the Coronavirus Impact Analysis on this Markets - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76521
Primary factors that are expected to accelerate the demand for rapid tests in the upcoming years include faster diagnostics and prevention of inappropriate use of antibiotics. At present, research and development activities are largely aimed at increasing the accuracy of rapid tests and make them more cost-effective. Despite the growing adoption of rapid tests, culture tests for antimicrobial susceptibility testing will continue to stay in demand. Rapid test kit is set to dominate the GAS pharyngitis diagnostics market in terms of market share and value.
More Trending Reports by Transparency Market Research –
Market Participants Focus on Development of New Assays for Faster Results
For companies operating within the current GAS pharyngitis diagnostics market, improving accuracy and speed of the overall diagnostic procedure is expected to be a major area of interest. Several companies are currently in the process of attaining approval from the US Food and Drug Administration (FDA). Some of the major players involved in the market, including Quidel Corporation and Abbott, are increasingly allocating funds for the development of new assays and a host of healthcare products. For instance, in October 2018, Abbott revealed that the US FDA approved the company's Influenza A & B 2 and Strep A 2 molecular assays. In addition, with the development of new assays, GAS pharyngitis diagnostics results can be achieved at a faster rate. In addition, the recently developed assays can be deployed in both patient as well as inpatient settings, such as physician offices, emergency rooms, walk-in clinics, etc. With additional research, new and cost-effective GAS pharyngitis diagnostics solutions that are currently in the research phase are projected to enter the market.
| Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up |
| More Trending Reports by Transparency Market Research – |
| Veterinary Orthopedic Implants Market: http://www.prnewswire.com/news-releases/high-prevalence-of-osteoarthritis-in-pets-underscoring-growth-in-veterinary-orthopedic-implants-market-from-2018-to-2026-tmr-301025379.html |
Comments
Post a Comment